Medical Specialists is pleased to announce we now supply the anti viral drug Tamiflu. Tamiflu is used for prevention of flu symptoms & also for treatment of flu symptoms such as Bird flu & Swine flu.
Antibiotics will not work against viruses and only an antiviral treatment such as Tamiflu will shorten the effects of flu strains like Swine Flu.
If you are interested in Tamiflu and would like to Buy Tamiflu online please visit www.medical-specialists.co.uk
Medical Specialist® are a registered UK pharmacy established in 1994 providing prescription & non prescription medication online since 2001.
Tuesday, 28 July 2009
Thursday, 16 July 2009
Hair
Hair loss Facts.
Hair loss affects approximately 40% of men and 20% of women aged 50 and over. In the US there are an estimated 40 million men and 12 million women suffering from some degree of baldness. The estimated market size for hair regeneration products and treatments is over $1 billion for both men and women but only 2% of patients suffering hair loss currently seek any treatment.
Existing Treatments.
Hair loss treatments available today a few and far between, so far there is only two medicines which have been licensed for use as a Male hair loss product. 1 Propecia & 2 Regaine.
Propecia is the more successful treatment out of the two and has many papers and happy customers that have used the product who have either stop hair loss in its tracks or regained lost hair.
Regaine can be bought over the counter at most pharmacies & supermarkets and has worked on a smaller percentage to some degree.
Hair Cloning
But now a company in Manchester called Intercytex have been busy working on cloning, hair cloning that is. Already phase 1 & 2 of the hair cloning trials have been completed and are showing some promising results.
The ICX-TRC procedure
A small sample of hair follicles is taken from the patient during a simple 30 minute operation carried out under local anaesthetic at a hair or skin clinic. The clinic sends the biopsy to Intercytex’ GMP compliant manufacturing facility where the DP cells are dissociated from the rest of the follicle. These cells are cultured and expanded in proprietary media over three weeks and subsequently returned to the clinic in a sterile suspension.
sing a specialised delivery system, the DP cells are microinjected intradermally into the patient’s scalp. The treatment is performed under local anaesthetic and comprises a single procedure of superficial injections, each injection delivering a minute volume of media containing DP cells. These cells are able to stimulate the generation of new hairs when injected in close proximity to the epidermal cells which generate the hair. Following the procedure, new hair growth should become evident after approximately three months.
ICX-TRC clinical and commercial development
For the full article please visit http://www.medical-specialists.co.uk/news/index.php/2009/07/16/hair-regeneration and feel free to leave comments either on here or on our main website..
Hair loss affects approximately 40% of men and 20% of women aged 50 and over. In the US there are an estimated 40 million men and 12 million women suffering from some degree of baldness. The estimated market size for hair regeneration products and treatments is over $1 billion for both men and women but only 2% of patients suffering hair loss currently seek any treatment.
Existing Treatments.
Hair loss treatments available today a few and far between, so far there is only two medicines which have been licensed for use as a Male hair loss product. 1 Propecia & 2 Regaine.
Propecia is the more successful treatment out of the two and has many papers and happy customers that have used the product who have either stop hair loss in its tracks or regained lost hair.
Regaine can be bought over the counter at most pharmacies & supermarkets and has worked on a smaller percentage to some degree.
Hair Cloning
But now a company in Manchester called Intercytex have been busy working on cloning, hair cloning that is. Already phase 1 & 2 of the hair cloning trials have been completed and are showing some promising results.
The ICX-TRC procedure
A small sample of hair follicles is taken from the patient during a simple 30 minute operation carried out under local anaesthetic at a hair or skin clinic. The clinic sends the biopsy to Intercytex’ GMP compliant manufacturing facility where the DP cells are dissociated from the rest of the follicle. These cells are cultured and expanded in proprietary media over three weeks and subsequently returned to the clinic in a sterile suspension.
sing a specialised delivery system, the DP cells are microinjected intradermally into the patient’s scalp. The treatment is performed under local anaesthetic and comprises a single procedure of superficial injections, each injection delivering a minute volume of media containing DP cells. These cells are able to stimulate the generation of new hairs when injected in close proximity to the epidermal cells which generate the hair. Following the procedure, new hair growth should become evident after approximately three months.
ICX-TRC clinical and commercial development
For the full article please visit http://www.medical-specialists.co.uk/news/index.php/2009/07/16/hair-regeneration and feel free to leave comments either on here or on our main website..
Subscribe to:
Posts (Atom)